News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jayastu Senapati: Optimal use of Azacytidine Venetoclax in AML Patients in Indian Scenario
Photo taken from Jayastu Senapati/X
May 21, 2024, 04:55

Jayastu Senapati: Optimal use of Azacytidine Venetoclax in AML Patients in Indian Scenario

Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared a post on X:

“Looking forward to discussing the optimal use of Hypomethylating Agent (HMA) – Venetoclax in patients with Acute Myeloid Leukaemia (AML), focussing on Indian/Low and Middle-Income Country (LMIC) settings- May 17, CT 8:30AM (IST 7PM).”

Additional information.
Source: Jayastu Senapati/X

Acute Myeloid Leukaemia cancer Hypomethylating agents (HMA) Jayastu Senapati Low and middle-income countries (LMIC) MD Anderson Cancer Cente OncoDaily Oncology venetoclax
Special Coverage
Science
Dec 21, 2024, 07:56
Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer
Science
Dec 21, 2024, 07:05
Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML
Blog
Dec 21, 2024, 05:54
LCC in Spanish: LALCA 2024 Highlights
Blog
Dec 21, 2024, 05:50
The Opportunities Are Endless: CU Cancer Center leader Enrique Soto Pérez de Celis signs key international agreement
Insight
Dec 21, 2024, 05:42
Raffaella Casolino: How to integrate cancer into crisis?
Insight
Dec 21, 2024, 05:01
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Blog
Dec 21, 2024, 05:01
Omolola Salako: A year ago, Pearl Oncology Specialist Hospital became a 24-hour, 10-bed cancer center
Science
Dec 21, 2024, 04:57
Alexandre Chan: Updates on repurposing riluzole as a treatment for cancer-related cognitive impairment
Blog
Dec 21, 2024, 04:55
Milan Mishkovikj: The Patient at the Center - Value-Based Healthcare in Oncology
Insight
Dec 21, 2024, 04:52
Do national cancer control plans address care and research for children and AYAs - SIOP